Pituitary Surgery in Elderly Patients: Is It Safe Beyond 75 Years?

As the global population ages, more elderly patients require surgical interventions, including pituitary surgery. However, data on the safety and effectiveness of pituitary surgery in patients aged 75 and older remain limited. This article explores a recent study evaluating surgical outcomes in this age group, shedding light on surgical feasibility, complications, and long-term results.

Study Overview

A retrospective study was conducted on 155 patients aged 75 and older who underwent surgery for pituitary adenomas and Rathke’s cleft cysts between 2008 and 2022. Their outcomes were compared to a control group of 2379 younger adult patients treated by the same expert neurosurgical team.

Key Findings

1. High Success Rate with Surgery

✅ 97% of patients achieved tumor volume control after a single surgery. ✅ 2-year and 5-year disease control rateswere 97.3% and 86.2%, respectively. ✅ No vision worsening occurred post-surgery. ✅ In patients with acromegaly or Cushing’s disease, 90% achieved endocrine remission when tumors were non-invasive.

2. Low Complication Rates

🔹 Surgical complications were observed in only 5% of patients. 🔹 30-day mortality rate was 0.6%. 🔹 Other complications: Hematoma (0.6%), Cerebrospinal fluid leak (1.9%), Meningitis (0.6%), and Epistaxis (1.3%). 🔹 No cases of persistent diabetes insipidus were recorded. 🔹 The complication rate was similar to younger patients.

Conclusion

This study confirms that pituitary surgery in patients aged 75 and older is both safe and effective, particularly when performed by experienced neurosurgical teams in tertiary centers. With low complication rates and high success rates, elderly patients can undergo surgery with confidence.